AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 177 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,366,000 | -22.3% | 89,910 | +2.3% | 0.65% | -8.1% |
| Q3 2018 | $1,758,000 | -13.6% | 87,910 | -15.8% | 0.70% | +13.2% |
| Q2 2018 | $2,035,000 | +0.7% | 104,370 | +4.1% | 0.62% | -7.6% |
| Q1 2018 | $2,020,000 | +1060.9% | 100,270 | +664.8% | 0.67% | +1082.5% |
| Q4 2017 | $174,000 | -25.3% | 13,110 | +3.5% | 0.06% | -14.9% |
| Q2 2017 | $233,000 | -30.9% | 12,670 | -15.3% | 0.07% | -16.2% |
| Q1 2017 | $337,000 | -35.2% | 14,950 | 0.0% | 0.08% | -32.8% |
| Q4 2016 | $520,000 | +19.0% | 14,950 | +35.8% | 0.12% | -16.8% |
| Q3 2015 | $437,000 | – | 11,010 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |